JP Morgan Downgrades ACOR, ALTH, AMGN, VPHM
JP Morgan has downgraded the following companies from Overweight to Neutral:
Acorda Therapeutics (NASDAQ: ACOR) PT lowered from $38 to $30
Allos Therapeutics (NASDAQ: ALTH)
Amgen (NASDAQ: AMGN) PT raised from $70 to $75
ViroPharma (NASDAQ: VPHM) $35 PT
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.